Bank Hapoalim Bm Merck & Co., Inc. Transaction History

Bank Hapoalim Bm

$772 Million
Q1 2024

A detailed history of Bank Hapoalim Bm transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bank Hapoalim Bm holds 22,594 shares of MRK stock, worth $2.84 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

22,594

Previous 22,224 1.66%

Holding current value

$2.84 Million

Previous $2.42 Million 23.03%

% of portfolio

0.39%

Previous 0.33%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$113.24 - $131.95 $41,898 - $48,821	370 Added 1.66%	22,594 $2.98 Million
Q4 2023 Jan 22, 2024	SELL	$100.18 - $109.02 $42,576 - $46,333	-425 Reduced 1.88%	22,224 $2.42 Million
Q3 2023 Oct 24, 2023	SELL	$102.95 - $114.33 $72,682 - $80,716	-706 Reduced 3.02%	22,649 $2.33 Million
Q2 2023 Jul 26, 2023	SELL	$108.61 - $118.38 $16,291 - $17,757	-150 Reduced 0.64%	23,355 $2.7 Million
Q1 2023 Apr 25, 2023	SELL	$102.94 - $114.86 $247,056 - $275,664	-2,400 Reduced 9.26%	23,505 $2.5 Million

Q4 2022 Jan 26, 2023	SELL	$87.44 - $112.11 $49,053 - $62,893	-561 Reduced 2.12%	25,905 $2.87 Million
Q2 2022 Jul 27, 2022	SELL	$83.49 - $94.64 $22,124 - $25,079	-265 Reduced 0.99%	26,466 $2.41 Million
Q1 2022 Apr 28, 2022	BUY	$73.51 - $82.4 $115,410 - $129,368	1,570 Added 6.24%	26,731 $2.19 Million
Q4 2021 Feb 04, 2022	BUY	$72.28 - $90.54 $281,602 - $352,743	3,896 Added 18.32%	25,161 $1.93 Million
Q3 2021 Oct 27, 2021	BUY	$71.68 - $78.83 $114,257 - $125,655	1,594 Added 8.1%	21,265 $1.6 Million
Q2 2021 Aug 05, 2021	BUY	$70.31 - $77.77 $58,216 - $64,393	828 Added 4.39%	19,671 $1.53 Million
Q1 2021 Apr 26, 2021	BUY	$68.86 - $81.11 $142,195 - $167,492	2,065 Added 12.31%	18,843 $1.45 Million
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $177,846 - $197,372	2,478 Added 17.33%	16,778 $1.37 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $32,931 - $37,327	-450 Reduced 3.05%	14,300 $1.19 Million
Q4 2019 Feb 03, 2020	SELL	$77.58 - $87.54 $93,096 - $105,048	-1,200 Reduced 7.52%	14,750 $1.34 Million
Q3 2019 Nov 01, 2019	SELL	$76.08 - $82.93 $197,808 - $215,618	-2,600 Reduced 14.02%	15,950 $1.32 Million
Q1 2019 May 07, 2019	SELL	$69.58 - $79.36 $33,746 - $38,489	-485 Reduced 2.55%	18,550 $1.54 Million
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $9,786 - $11,356	-150 Reduced 0.78%	19,035 $1.45 Million
Q2 2018 Jul 24, 2018	BUY	$50.83 - $59.72 $336,494 - $395,346	6,620 Added 52.69%	19,185 $1.17 Million
Q1 2018 Apr 30, 2018	BUY	$50.96 - $59.23 $52,488 - $61,006	1,030 Added 8.93%	12,565 $684,000
Q4 2017 Feb 05, 2018	BUY	$51.62 - $61.64 $93,432 - $111,568	1,810 Added 18.61%	11,535 $0
Q3 2017 Nov 07, 2017	BUY	$58.67 - $63.13 $222,652 - $239,578	3,795 Added 64.0%	9,725 $623,000
Q2 2017 Aug 11, 2017	BUY	N/A	5,930	5,930 $380,000

Others Institutions Holding MRK

# of Institutions

3,768

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

News

Stay updated on Bank Hapoalim Bm with notifications on news.

Account